The Cigna Group (CI)
The Cigna Group (CI) Q1 2026 Earnings Call Transcript
The Cigna Group (CI) Q1 2026 Earnings Call Transcript
Cigna (CI) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cigna is becoming the second major insurer to exit from the ACA market as millions drop coverage with the expiration of federal subsidies.
Cigna Group will exit the Affordable Care Act market next year, citing an effort to focus on other lines of business.
Cigna Plans To Exit Obamacare In 2027 Affecting 369,000 With Coverage
The Cigna Group Thursday confirmed plans to exit the individual health insurance business also known as Obamacare next year, leaving about 369,00 health plan members in 11 states looking for new coverage in 2027.
Cigna (CI) Q1 Earnings and Revenues Beat Estimates
Cigna (CI) came out with quarterly earnings of $7.79 per share, beating the Zacks Consensus Estimate of $7.62 per share. This compares to earnings of $6.74 per share a year ago.
Cigna Revenue Rises on Evernorth Growth
Cigna Group logged higher profit and revenue in its latest quarter as its pharmacy-benefit business Evernorth continued to grow.
Cigna raises annual profit forecast after quarterly beat
Cigna slightly raised its annual adjusted profit forecast on Thursday after beating first-quarter earnings estimates, helped by strength in its health services unit and as medical costs came in lower than expected.
Cigna (CI) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Get a deeper insight into the potential performance of Cigna (CI) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Will Lower Premiums Affect Cigna's Q1 Earnings? Key Insights Here
CI approaches Q1 results with strong pharmacy growth but a steep premium drop, as estimates point to mixed year-over-year performance.
Cigna (CI) Reports Next Week: Wall Street Expects Earnings Growth
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Cigna: Flashing A Buy For Dividend Growth And Deep Value
Cigna Group remains a Buy, with catalysts for double-digit adjusted income per share growth resuming in 2027 and beyond. CI's pharmacy segment, biosimilar adoption, behavioral health expansion, and aggressive share buybacks drive both topline and margin growth. Shares trade at an 8.5x forward P/E, a 29% discount to fair value, supporting a projected 17% annual total return through 2031.
